SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
GEHC

GE HealthCare Technologies Inc. (NASDAQ:GEHC)

US · Delayed Price · Currency is USD
Healthcare · Medical - Devices
$80.64-$1.25 (-1.53%)
 
Market cap
$36.5B
Insider Score
Health Score
Analyst consensus
Listed since
Dec 15, 2022 · Spin-off
Market Cap$36.46B+3.1%
Revenue (ttm)$21.64B+6.9%
Net Income$2.17B-2.3%
EPS$4.74-2.1%
Shares Out452.14M
PE Ratio17.01
Forward PE14.59
Dividend$0.14(0.18%)
Ex-Dividend DateOct 23, 2026
Volume3,770,992
Open$82.53
Previous Close$81.89
Day's Range$80.30 - $83.07
52-Week Range$58.75 - $89.77
Beta0.77
AnalystsBuy
Price Target$81.22(+0.72%)
Earnings DateFeb 3, 2027

About GEHC

GE HealthCare Technologies Inc. is a global medical technology company that creates, manufactures, and markets a diverse range of medical devices, services, and integrated digital solutions. These offerings are designed to assist in the diagnosis, treatment, and ongoing monitoring of patients. The company boasts an extensive international presence, serving markets across the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, and Hong Kong, among other regions. Its operations are structured across four primary business divisions: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging division specializes in advanced diagnostic imaging technologies, including systems for molecular imaging, Computed Tomography (CT) scans, Magnetic Resonance (MR) imaging, image-guided therapy, and X-ray, alongside specialized women's health products. The Ultrasound segment delivers a comprehensive suite of ultrasound solutions utilized for the screening, diagnosis, treatment, and monitoring of various diseases. These applications span radiology, primary care, women's health, cardiovascular diagnostics, point-of-care, and portable handheld devices, in addition to products supporting surgical visualization and guidance. The Patient Care Solutions segment is dedicated to providing essential medical devices, consumable products, services, and digital platforms. Its portfolio encompasses patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal-infant care products. The Pharmaceutical Diagnostics segment supplies specialized diagnostic agents to the radiology and nuclear medicine industries. These include contrast media pharmaceuticals, administered to patients prior to scans like CT, angiography, X-ray, and MR, to enhance the visibility of internal tissues and structures. It also offers molecular imaging agents, or radiopharmaceuticals – molecular tracers labeled with radioisotopes – injected into patients for advanced diagnostic imaging applications such as Single-Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), and specific ultrasound procedures. Established in 2022, GE HealthCare Technologies Inc. maintains its corporate headquarters in Chicago, Illinois.

Address
500 West Monroe Street, Chicago, IL, 60661, US
Market Cap
36.46 billion
Employees
54,000
Industrial Classification
Medical - Devices

What Are Insiders Doing?

Open-market buy / sell balanceNet Buying
Sold
$0
Bought
$805.17K

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Analyst consensus

Moderate Buy
5 Buy3 Hold0 SellAvg target $81.25 (-2.9%)

8 firms rating GEHC in the last 3 months, one vote each. Issuer-paid research is not counted.

Financial Health Score
Sound
From GEHC’s reported statements · Q3 2026 (trailing 12 months)

Next catalysts

1 Day
-1.53%
5 Days
-3.38%
1 Month
+12.91%
6 Months
+25.55%
1 Year
+3.07%

$GEHC stock is featured in our Congress Trading, and Insider Trades datasets.

→ All Stock Lists

Congress Trading

Recent trades of GEHC by members of U.S. Congress

Ro KhannaHouse / DPurchase$1.00K – $15.00KSep 11, 2026
Ro KhannaHouse / DPurchase$1.00K – $15.00KJul 2, 2026
Alan ArmstrongSenate / RPurchase$1.00K – $15.00KMar 27, 2026
Terri SewellHouse / DSale$1.00K – $15.00KMar 25, 2026
Austin ScottHouse / RSale$1.00K – $15.00KMar 27, 2025
Michael T. McCaulHouse / RSale$100.00K – $250.00KJan 20, 2023

Recently reported changes in GEHC holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by GEHC's directors and management

Net Shares Purchased by Insiders−20k−10k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

GEHC Estimated quarterly lobbying spending

Source: U.S. Senate LDA

GEHC Revenue by Segment or Geography

$5.51BTotal
AIS$3.87B70.24%
PDx$846.00M15.34%
PCS$793.00M14.38%
Other$2.00M0.04%

As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New GEHC patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to GEHC from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in GEHC

VOOVanguard S&P 500 ETF$919.04M
VTIVanguard Morningstar Total Stock Market ETF$866.64M
QQQInvesco QQQ Trust, Series 1$794.36M
VOVanguard Morningstar Mid-Cap ETF$738.84M
IVViShares Core S&P 500 ETF$498.31M
SPYState Street SPDR S&P 500 ETF$450.77M

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from GEHC’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
48% of score
74.15
Analyst Ratings
32% of score
78
News & Sentiment
20% of score
72

News check: Multiple positive clinical and regulatory achievements including FDA approval, Phase 3 advancement, and new AI products offset neutral guidance updates.

Recent Insider Activity

Buys
3
Sells
0
Buy Value
$805.17K
Distinct Buyers
3

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

CSDInvesco S&P Spin-Off ETF9.41%
MVALVanEck ETF Trust - VanEck Morningstar Wide Moat Value ETF5.11%
FDHTFIDELITY DIGITAL HEALTH ETF4.76%
HEALGlobal X HealthTech ETF4.66%
IHIiShares U.S. Medical Devices ETF4.62%
FEMDFirst Eagle Mid Cap Equity ETF2.91%
MOATVanEck Morningstar Wide Moat ETF2.90%
CNAVMohr Company Nav ETF2.59%
HWGVHotchkis & Wiley Global Value Fund2.47%
MDEVFirst Trust Indxx Medical Devices ETF2.35%
FHH.TOFirst Trust AlphaDEX U.S. Health Care Sector Index ETF2.30%
FXHFirst Trust Health Care AlphaDEX Fund2.29%

Weight is the stock’s share of each fund’s holdings.